Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Meyvisch

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pharmaceutical Statistics|February 15, 2024
On sample size calculation in drug interaction trialsPaul Meyvisch, Mitra Ebrahimpoor
Journal of Biopharmaceutical Statistics|April 14, 2026
A geometrically intuitive framework for the synthesis method in non-inferiority trialsAlberto Garcia-Hernandez, Paul Meyvisch
Statistics in Medicine|December 15, 2016
Assessing a surrogate predictive value: a causal inference approachAriel Alonso, Wim Van der Elst, Paul Meyvisch
Statistics in Medicine|September 3, 2020
On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomesPaul Meyvisch, Ariel Alonso, Wim Van der Elst, et al.
Pharmaceutical Statistics|December 22, 2018
Assessing the predictive value of a binary surrogate for a binary true endpoint based on the minimum probability of a prediction errorPaul Meyvisch, Ariel Alonso, Wim Van der Elst, et al.
Journal of Biopharmaceutical Statistics|January 29, 2019
A reflection on the possibility of finding a good surrogateAriel Alonso, Paul Meyvisch, Wim Van der Elst, et al.
Pharmaceutical Statistics|May 21, 2021
The individual-level surrogate threshold effect in a causal-inference setting with normally distributed endpointsWim Van der Elst, Ariel Alonso Abad, Hans Coppenolle, et al.
Epilepsia|March 1, 2007
Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizuresMichel Baulac, Martin J Brodie, Christian E Elger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Safety and pharmacokinetics of the HIV-1 protease inhibitor TMC310911 coadministered with ritonavir in healthy participants: results from 2 phase 1 studiesRichard M W Hoetelmans, Inge Dierynck, Ilham Smyej, et al.
Frontiers in Medicine|July 26, 2024
Interactive medical and safety monitoring in clinical trials with clinDataReview: a validated and open-source reporting toolLaure Cougnaud, Margaux Faes, Dirk Van Krunckelsven, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|February 15, 2024
On sample size calculation in drug interaction trialsPaul Meyvisch, Mitra Ebrahimpoor
Journal of Biopharmaceutical Statistics|April 14, 2026
A geometrically intuitive framework for the synthesis method in non-inferiority trialsAlberto Garcia-Hernandez, Paul Meyvisch
Statistics in Medicine|December 15, 2016
Assessing a surrogate predictive value: a causal inference approachAriel Alonso, Wim Van der Elst, Paul Meyvisch
Statistics in Medicine|September 3, 2020
On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomesPaul Meyvisch, Ariel Alonso, Wim Van der Elst, et al.
Pharmaceutical Statistics|December 22, 2018
Assessing the predictive value of a binary surrogate for a binary true endpoint based on the minimum probability of a prediction errorPaul Meyvisch, Ariel Alonso, Wim Van der Elst, et al.
Journal of Biopharmaceutical Statistics|January 29, 2019
A reflection on the possibility of finding a good surrogateAriel Alonso, Paul Meyvisch, Wim Van der Elst, et al.
Pharmaceutical Statistics|May 21, 2021
The individual-level surrogate threshold effect in a causal-inference setting with normally distributed endpointsWim Van der Elst, Ariel Alonso Abad, Hans Coppenolle, et al.
Epilepsia|March 1, 2007
Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizuresMichel Baulac, Martin J Brodie, Christian E Elger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2013
Safety and pharmacokinetics of the HIV-1 protease inhibitor TMC310911 coadministered with ritonavir in healthy participants: results from 2 phase 1 studiesRichard M W Hoetelmans, Inge Dierynck, Ilham Smyej, et al.
Frontiers in Medicine|July 26, 2024
Interactive medical and safety monitoring in clinical trials with clinDataReview: a validated and open-source reporting toolLaure Cougnaud, Margaux Faes, Dirk Van Krunckelsven, et al.
Pageof 2